PARP inhibitorPhase 3 trialInvestigational
PARP inhibitor
How it works
Blocks the repair of DNA damage in cancer cells, causing them to die.
Cancer types
Prostate Cancer— Patients with BRCA mutations
Efficacy
Studies show that PARP inhibitors can improve overall survival in around 30% of patients with BRCA mutations.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Combining PARP Inhibitors and Platinum May Enhance Lung Cancer Treatment | Lung Cancer | lab-study | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.